ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed

November 26, 1999

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

CDC Study Finds No Correlation Between Alcohol, Breast Cancer

April 8, 1988

In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget

July 7, 1995